Mutual, however, argues that federal law preempts this type of claim, because the FDA had already approved its drug and federal law also requires a generic drug to have the same design as the brand-name medication ( here is the petition).

FORBES: Good For Generic Drugmakers? White House To Argue In Favor Of Preemption